Bio-Techne Corp.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $1.70B | $172.6M |
| FY2023 | — | $1.97B | $180.6M |
| FY2024 | — | $2.07B | $151.8M |
| FY2025 | — | $1.92B | $162.2M |
| FY2026 | — | $2.11B | $264.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | — | $1.70B | $172.6M |
| FY2023 | — | $1.97B | $180.6M |
| FY2024 | — | $2.07B | $151.8M |
| FY2025 | — | $1.92B | $162.2M |
| FY2026 | — | $2.11B | $264.7M |